BIBP 5371
Alternative Names: BIBP-5371-CL; BIBP5371Latest Information Update: 31 Oct 2021
At a glance
- Originator Boehringer Ingelheim
- Class
- Mechanism of Action Calcitonin gene-related peptide receptor antagonists
- 
          
            
              Orphan Drug Status
              NoOrphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. 
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
